Atea Pharmaceuticals
AVIR
#8191
Rank
ยฃ0.18 B
Marketcap
ยฃ2.40
Share price
0.95%
Change (1 day)
1.41%
Change (1 year)

Revenue for Atea Pharmaceuticals (AVIR)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atea Pharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A-100%
2021 ยฃ0.26 B629.57%
2020 ยฃ35.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA